ACDM News Item

Risk Based Quality Management DMEG Update – Recent Discussions

Date: October 16, 2024

This year our focus has switched away from generalised RBQM to applying risk-based approaches to delivering Data Management. This is a huge topic and one that has stimulated much conversation over the course of our recent meetings. The DMEG has invested much discussion into the fundamentals of Risk-Based Data Management as well as discussions on how to pivot operational practices accordingly. We have been lucky to hear practical insights from some the DMEG members in these areas from projects that have or are running in their organisations.

Given the wealth of information and discussion that has taken place in the DMEG this year, our aim is now to distill our discussion and learnings into a paper that we can share with the wider ACDM membership. We look forward to being able to share more insights on this topic in due course.

– Rich Davies, Risk Based Quality Management (RBQM) DMEG Chair

Find out more about the RBQM DMEG here.

Explore More News

Regulatory Considerations DMEG Shares Update on ICH E6(R3) Training Modules Available

The ICH Working Groups and The ICH Training Associates have released two new training . . .

Recent update from the regulatory landscape in clinical data management

On 22 September, MHRA published a new set of inspection dossier documents specifically for . . .

Regulatory Considerations DMEG Update – August 2026

Please read the following update from the Regulatory Considerations DMEG: July and . . .

Get to know ACDM Board Member: Santosh Karthikeyan Viswanathan

We caught up with one of ACDM’s new Board Members, Santosh Karthikeyan Viswanathan, to . . .

Guidance on Decentralized Clinical Trials to be Reviewed by the ACDM RC DMEG

Health Canada (HC) continues to publish new guidelines to support their modernization of . . .

Regulatory Considerations DMEG to Review Health Canada’s Draft Guidance

Thank you to the Regulatory Considerations DMEG for sharing this update. Health Canada . . .

Recent update from the regulatory landscape in clinical data management

Thank you to the Regulatory Considerations DMEG for sharing this update. On July 15 the . . .

Regulatory Considerations DMEG Update – June 2026

Please read the following update from the Regulatory Considerations DMEG: Regulators have . . .

FDA Announces New Initiative for Real-Time Clinical Trials

The U.S. Food and Drug Administration (FDA) has announced a new initiative to support the . . .

Get to know ACDM Board Member Jennifer Duff

We caught up with one of ACDM’s new Board Members, Jennifer Duff, to learn more about her. . . .

Recent News in Regulatory Landscape

The ACDM Regulatory Considerations DMEG have kindly put together a short news piece . . .

Real-Time Clinical Data Flow: Why the FDA’s New Pilot Validates the Data Flow Modernization Agenda

Tamer Chowdhury, on behalf of ACDM Technology DMEG. On April 28, FDA Commissioner Dr. . . .